Deal gives German pharma giant access to surgery-free permanent birth control procedure
Bayer Healthcare has agreed to buy US specialist women’s health company Conceptus for $1.1 billion (£709 million).
The deal gives Bayer access to Essure, a non-surgical procedure for permanent birth control. Essure has been approved in the US since 2002, and involves placing soft, flexible inserts inside the fallopian tubes via the cervix. Over three months, tissue grows through these inserts to form a barrier that prevents sperm from reaching the eggs.